3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Conditions
Melanoma
23
Carcinoma, Non-Small-Cell Lung
10
Colorectal Neoplasms
7
Neoplasms
5
Neoplasm Metastasis
5
Skin Neoplasms
4
Lung Neoplasms
4
Pancreatic Neoplasms
3
Uveal Melanoma
2
Triple Negative Breast Neoplasms
2
Skin Diseases
2
Hereditary Sensory and Autonomic Neuropathies
2
Brain Neoplasms
2
Thyroid Neoplasms
1
Thyroid Diseases
1
Spinocerebellar Degenerations
1
Solid Tumors Harboring a BRAF V600 Mutation
1
Solid Tumors
1
Solid Tumor
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Noonan Syndrome 5
1
Neurofibromatosis 1
1
Low-grade Serous Ovarian Cancer
1
Leukemia, Myeloid, Acute
1
Hematologic Neoplasms
1
Glioma
1
Gastrointestinal Stromal Tumors
1
Fallopian Tube Neoplasms
1
Interventions
tovorafenib
1
binimetinib
1
Carboplatin
1
Antineoplastic Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Noonan Syndrome 5
×
binimetinib
×
Clear all
NCT01885195
2021-02-21
SIGNATURE
Pfizer
Phase 2
Completed
110 enrolled
18 charts